Skip to main content
Erschienen in: Inflammation 5/2018

28.06.2018 | ORIGINAL ARTICLE

PI3K/AKT and CD40L Signaling Regulate Platelet Activation and Endothelial Cell Damage in Sepsis

verfasst von: Peng Wan, Xiang Tan, Yan Xiang, Huasheng Tong, Min Yu

Erschienen in: Inflammation | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Platelets contribute to inflammation and their activation has been suggested as versatile effectors of sepsis. Activation of platelets promotes secretion of CD40L that induces sepsis and multiple organ dysfunction syndrome (MODS). However, the mechanisms regulate platelet-derived CD40L are not fully understood. Activation of PI3K/Akt pathway has been reported as a key component of sepsis, whereas the role of PI3K/Akt pathway in platelet-derived CD40L is unknown. In this study, we identified PI3K/Akt pathway as a key regulator of CD40L secretion by platelets. Significantly, inhibition of PI3K/Akt pathway by Ly294002 attenuated platelet activation and CD40L production. Moreover, PI3K/Akt pathway blocking suppresses vascular endothelial cells in vivo. Furthermore, the expression of biomarkers that represent the severity of sepsis, such as ICAM-1, VCAM-1, and E-selectin, was also suppressed by Ly294002. Altogether, our results confirm the pivotal role of PI3K/Akt pathway in sepsis and its inhibition might be a potential therapeutic target.
Literatur
1.
Zurück zum Zitat Hou, T., D. Huang, R. Zeng, Z. Ye, and Y. Zhang. 2015. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine 8 (9): 15238–15245.PubMedPubMedCentral Hou, T., D. Huang, R. Zeng, Z. Ye, and Y. Zhang. 2015. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine 8 (9): 15238–15245.PubMedPubMedCentral
9.
Zurück zum Zitat Aloui, C., A. Prigent, C. Sut, S. Tariket, H. Hamzeh-Cognasse, B. Pozzetto, Y. Richard, F. Cognasse, S. Laradi, and O. Garraud. 2014. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. International Journal of Molecular Sciences 15 (12): 22342–22364. https://doi.org/10.3390/ijms151222342.CrossRefPubMed Aloui, C., A. Prigent, C. Sut, S. Tariket, H. Hamzeh-Cognasse, B. Pozzetto, Y. Richard, F. Cognasse, S. Laradi, and O. Garraud. 2014. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. International Journal of Molecular Sciences 15 (12): 22342–22364. https://​doi.​org/​10.​3390/​ijms151222342.CrossRefPubMed
11.
Zurück zum Zitat Kawabe, T., M. Matsushima, N. Hashimoto, K. Imaizumi, and Y. Hasegawa. 2011. CD40/CD40 ligand interactions in immune responses and pulmonary immunity. Nagoya Journal of Medical Science 73 (3–4): 69–78.PubMedPubMedCentral Kawabe, T., M. Matsushima, N. Hashimoto, K. Imaizumi, and Y. Hasegawa. 2011. CD40/CD40 ligand interactions in immune responses and pulmonary immunity. Nagoya Journal of Medical Science 73 (3–4): 69–78.PubMedPubMedCentral
19.
Zurück zum Zitat Lone, M.U., K.S. Baghel, R.K. Kanchan, R. Shrivastava, S.A. Malik, B.N. Tewari, C. Tripathi, et al. 2016. Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells. Oncogene. https://doi.org/10.1038/onc.2016.346. Lone, M.U., K.S. Baghel, R.K. Kanchan, R. Shrivastava, S.A. Malik, B.N. Tewari, C. Tripathi, et al. 2016. Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells. Oncogene. https://​doi.​org/​10.​1038/​onc.​2016.​346.
20.
Zurück zum Zitat Boisrame-Helms, J., H. Kremer, V. Schini-Kerth, and F. Meziani. 2013. Endothelial dysfunction in sepsis. Current Vascular Pharmacology 11 (2): 150–160.PubMed Boisrame-Helms, J., H. Kremer, V. Schini-Kerth, and F. Meziani. 2013. Endothelial dysfunction in sepsis. Current Vascular Pharmacology 11 (2): 150–160.PubMed
22.
Zurück zum Zitat Cines, D.B., E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, R.P. McEver, J.S. Pober, et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (10): 3527–3561.PubMed Cines, D.B., E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, R.P. McEver, J.S. Pober, et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (10): 3527–3561.PubMed
24.
Zurück zum Zitat Vincent, J.L., A. Yagushi, and O. Pradier. 2002. Platelet function in sepsis. Critical Care Medicine 30 (5 Suppl): S313–S317.CrossRefPubMed Vincent, J.L., A. Yagushi, and O. Pradier. 2002. Platelet function in sepsis. Critical Care Medicine 30 (5 Suppl): S313–S317.CrossRefPubMed
29.
Zurück zum Zitat Aird, W.C. 2004. Endothelium as an organ system. Critical Care Medicine 32 (5 Suppl): S271–S279.CrossRefPubMed Aird, W.C. 2004. Endothelium as an organ system. Critical Care Medicine 32 (5 Suppl): S271–S279.CrossRefPubMed
32.
Zurück zum Zitat Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (6412): 539–541. https://doi.org/10.1038/361539a0.CrossRefPubMed Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (6412): 539–541. https://​doi.​org/​10.​1038/​361539a0.CrossRefPubMed
34.
Zurück zum Zitat Aggarwal, A., D.J. Schneider, E.F. Terrien, B.E. Sobel, and H.L. Dauerman. 2004. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. The American Journal of Cardiology 93 (1): 6–9.CrossRefPubMed Aggarwal, A., D.J. Schneider, E.F. Terrien, B.E. Sobel, and H.L. Dauerman. 2004. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. The American Journal of Cardiology 93 (1): 6–9.CrossRefPubMed
36.
Zurück zum Zitat Lerman, Y.V., and M. Kim. 2015. Neutrophil migration under normal and sepsis conditions. Cardiovascular & Hematological Disorders Drug Targets 15 (1): 19–28.CrossRef Lerman, Y.V., and M. Kim. 2015. Neutrophil migration under normal and sepsis conditions. Cardiovascular & Hematological Disorders Drug Targets 15 (1): 19–28.CrossRef
37.
Zurück zum Zitat Bagshaw, S.M., S. Uchino, R. Bellomo, H. Morimatsu, S. Morgera, M. Schetz, I. Tan, C. Bouman, E. Macedo, N. Gibney, A. Tolwani, H.M. Oudemans-van Straaten, C. Ronco, J.A. Kellum, and for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. 2007. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clinical Journal of the American Society of Nephrology 2 (3): 431–439. https://doi.org/10.2215/CJN.03681106. CrossRefPubMed Bagshaw, S.M., S. Uchino, R. Bellomo, H. Morimatsu, S. Morgera, M. Schetz, I. Tan, C. Bouman, E. Macedo, N. Gibney, A. Tolwani, H.M. Oudemans-van Straaten, C. Ronco, J.A. Kellum, and for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. 2007. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clinical Journal of the American Society of Nephrology 2 (3): 431–439. https://​doi.​org/​10.​2215/​CJN.​03681106.​ CrossRefPubMed
38.
Zurück zum Zitat Cantley, L.C., and B.G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings of the National Academy of Sciences of the United States of America 96 (8): 4240–4245.CrossRefPubMedPubMedCentral Cantley, L.C., and B.G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings of the National Academy of Sciences of the United States of America 96 (8): 4240–4245.CrossRefPubMedPubMedCentral
Metadaten
Titel
PI3K/AKT and CD40L Signaling Regulate Platelet Activation and Endothelial Cell Damage in Sepsis
verfasst von
Peng Wan
Xiang Tan
Yan Xiang
Huasheng Tong
Min Yu
Publikationsdatum
28.06.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0824-5

Weitere Artikel der Ausgabe 5/2018

Inflammation 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.